These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38183745)
1. Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement. Comella F; Lama A; Pirozzi C; Annunziata C; Piegari G; Sodano F; Melini S; Paciello O; Lago Paz F; Meli R; Mattace Raso G Biomed Pharmacother; 2024 Feb; 171():116094. PubMed ID: 38183745 [TBL] [Abstract][Full Text] [Related]
2. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells. Chen L; Li L; Chen J; Li L; Zheng Z; Ren J; Qiu Y Oncotarget; 2015 Dec; 6(40):42530-40. PubMed ID: 26729705 [TBL] [Abstract][Full Text] [Related]
3. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury. Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644 [TBL] [Abstract][Full Text] [Related]
4. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890 [TBL] [Abstract][Full Text] [Related]
5. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613 [TBL] [Abstract][Full Text] [Related]
6. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181 [TBL] [Abstract][Full Text] [Related]
7. Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis. Livingston MJ; Shu S; Fan Y; Li Z; Jiao Q; Yin XM; Venkatachalam MA; Dong Z Autophagy; 2023 Jan; 19(1):256-277. PubMed ID: 35491858 [TBL] [Abstract][Full Text] [Related]
8. N-Oleoylethanolamine Reduces Inflammatory Cytokines and Adhesion Molecules in TNF-α-induced Human Umbilical Vein Endothelial Cells by Activating CB2 and PPAR-α. Xu X; Guo H; Jing Z; Yang L; Chen C; Peng L; Wang X; Yan L; Ye R; Jin X; Wang Y J Cardiovasc Pharmacol; 2016 Oct; 68(4):280-291. PubMed ID: 27281236 [TBL] [Abstract][Full Text] [Related]
9. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells. Martínez de Ubago M; García-Oya I; Pérez-Pérez A; Canfrán-Duque A; Quintana-Portillo R; Rodríguez de Fonseca F; González-Yanes C; Sánchez-Margalet V Biochim Biophys Acta; 2009 Aug; 1791(8):740-5. PubMed ID: 19345745 [TBL] [Abstract][Full Text] [Related]
10. Suppression of TRPM2 reduces renal fibrosis and inflammation through blocking TGF-β1-regulated JNK activation. Wang Y; Chen L; Wang K; Da Y; Zhou M; Yan H; Zheng D; Zhong S; Cai S; Zhu H; Li Y Biomed Pharmacother; 2019 Dec; 120():109556. PubMed ID: 31655312 [TBL] [Abstract][Full Text] [Related]
11. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway. Cai P; Liu X; Xu Y; Qi F; Si G Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449 [TBL] [Abstract][Full Text] [Related]
12. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition. Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738 [TBL] [Abstract][Full Text] [Related]
13. Oleoylethanolamide inhibits glial activation via moudulating PPARα and promotes motor function recovery after brain ischemia. Luo D; Zhang Y; Yuan X; Pan Y; Yang L; Zhao Y; Zhuo R; Chen C; Peng L; Li W; Jin X; Zhou Y Pharmacol Res; 2019 Mar; 141():530-540. PubMed ID: 30660821 [TBL] [Abstract][Full Text] [Related]
14. Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells. Chen Y; Luo Q; Xiong Z; Liang W; Chen L; Xiong Z Int J Clin Exp Pathol; 2012; 5(6):522-9. PubMed ID: 22949934 [TBL] [Abstract][Full Text] [Related]
15. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway. Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859 [TBL] [Abstract][Full Text] [Related]
16. Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury. Sharma A; Kilari S; Cai C; Simeon ML; Misra S Am J Physiol Renal Physiol; 2020 May; 318(5):F1210-F1219. PubMed ID: 32200666 [TBL] [Abstract][Full Text] [Related]
17. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes. Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Hosseinzadeh-Attar MJ; Shakeri A; Asghari-Jafarabadi M; Roshanravan N; Farrin N; Naemi M; Hasankhani M Pharmacol Res; 2020 Jun; 156():104770. PubMed ID: 32217148 [TBL] [Abstract][Full Text] [Related]
18. Metformin attenuates folic-acid induced renal fibrosis in mice. Yi H; Huang C; Shi Y; Cao Q; Zhao Y; Zhang L; Chen J; Pollock CA; Chen XM J Cell Physiol; 2018 Sep; 233(9):7045-7054. PubMed ID: 29380373 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats. Qi FH; Cai PP; Liu X; Si GM Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600 [TBL] [Abstract][Full Text] [Related]
20. The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice. Cluny NL; Keenan CM; Lutz B; Piomelli D; Sharkey KA Neurogastroenterol Motil; 2009 Apr; 21(4):420-9. PubMed ID: 19140957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]